News

MathWorks Showcases AI for Safety-Critical Systems at NeurIPS 2025

December 2, 2025 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)–NeurIPS 2025, Booth #732 – MathWorks, the leading developer of mathematical computing software, will showcase how engineers and scientists can use MATLAB® and Simulink® to design, verify, and deploy AI-driven systems for safety-critical […]

Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares

December 1, 2025 SDBN Comments Off

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant […]

New Bilingual Opera Explores Migrant Journey in ‘Pancho Rabbit and the Coyote’

December 1, 2025 SDBN Comments Off

Pulitzer Prize–winning composer Anthony Davis and nationally acclaimed playwright and librettist Allan Havis, both professors at the University of California San Diego, will debut their new bilingual chamber opera, “Pancho Rabbit and the Coyote,” in […]

Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC

December 1, 2025 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)—- $JANX–Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC Click here to view original post Click Here to Publish/Feature Your Company or Product News […]

Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares

December 1, 2025 SDBN Comments Off

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet […]

The Inner Circle acknowledges, Kari Lynn Purcott, MD, FACOG, as a Pinnacle Lifetime Member

December 1, 2025 SDBN Comments Off

CARLSBAD, Calif., Dec. 1, 2025 /PRNewswire/ — Prominently featured in The Inner Circle, Kari Lynn Purcott, MD, FACOG is acknowledged as a Pinnacle Lifetime Member for her contributions to Empowering Women’s Health with Compassionate Care. […]

AltPep Corporation Presents New Preclinical Data at CTAD 2025 Demonstrating SOBIN-AD, its Custom-Designed Peptide for Alzheimer’s Disease, Improves Behavior in Both Symptomatic and Asymptomatic Disease

December 1, 2025 SDBN Comments Off

SEATTLE–(BUSINESS WIRE)– #Alzheimers–AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, will present preclinical data at the Clinical Trials on Alzheimer’s Disease Conference (CTAD), taking place December […]

Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer’s Disease

December 1, 2025 SDBN Comments Off

Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with best-in-class performance SAN DIEGO, Dec. 1, 2025 /PRNewswire/ — Circular Genomics, Inc., the world-leading developer […]

Connect Strengthens Leadership Team with Promotion of Cait Kelly to Chief Strategy Officer

December 1, 2025 SDBN Comments Off

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Connect, the premier nonprofit organization in San Diego’s innovation ecosystem dedicated to supporting entrepreneurs and cultivating thriving life science and technology communities, announced today that Cait Kelly […]

INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer’s Patients

December 1, 2025 SDBN Comments Off

Boca Raton, FL, Dec. 01, 2025 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing inflammation and immunology therapies targeting innate immune dysfunction, announces new neuroimaging data from its Phase 2 […]

Nobel Prize-Winning Metal-Organic Frameworks Are the Jungle Gyms of Chemistry

December 1, 2025 SDBN Comments Off

UC San Diego chemistry professor Seth Cohen has made a career out of studying and developing metal-organic frameworks. Currently, his lab is working to develop modified MOFs with new characteristics and capabilities. Here he explains […]

New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease

December 1, 2025 SDBN Comments Off

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”) today announced topline results from the global Phase 3 “DRAGON” trial of Tinlarebant, marking the first successful […]

Protego gets $130M for AL amyloidosis drug from leaders behind Vyndaqel

December 1, 2025 SDBN Comments Off

A San Diego biotech hoping to crack into a rare protein misfolding disease has drummed up $130 million in investor support to get into a potential pivotal trial next year. Protego Biopharma, from the … […]

Protego Biopharma Raises $130 Million Oversubscribed Series B Financing to Advance First-in-Class AL Amyloidosis Program into Pivotal Study

December 1, 2025 SDBN Comments Off

Financing led by Novartis Venture Fund and Forbion, with new investment from Omega Funds, Droia Ventures, YK Bioventures, and Digitalis Ventures Renewed backing from Vida Ventures, MPM BioImpact, Lightspeed Venture Partners, and Scripps Research SAN […]

Telix Pharmaceuticals Ltd. Shareholders with Large Losses Should Contact Robbins LLP for Information About the TLX Class Action

November 28, 2025 SDBN Comments Off

SAN DIEGO, Nov. 28, 2025 /PRNewswire/ — Company: Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. What is the […]

Scripps Oceanography Seismologist Awarded for Real-Time Tsunami Forecast Breakthrough

November 25, 2025 SDBN Comments Off

Scripps’ Alice Gabriel is part of a team awarded the 2025 Association for Computing Machinery (ACM) Gordon Bell Prize for its work on real-time tsunami forecasting. The researchers created algorithms to forecast tsunami wave heights […]

Nine Breakthroughs Made Possible by AI

November 25, 2025 SDBN Comments Off

The rise of artificial intelligence has already transformed every facet of our lives at a remarkable speed. At UC San Diego, AI is empowering bold advances in science, education, public safety, health and the arts. […]

Genetic Study Links Impulsive Decision Making to a Wide Range of Health and Psychiatric Risks

November 25, 2025 SDBN Comments Off

University of California San Diego has identified 11 genetic regions linked to delay discounting — the tendency to prefer smaller, immediate rewards over larger, delayed ones — shedding new light on how impulsive decision-making relates […]

IQHQ Halts Development On $1B Fenway Center Life Sciences Project

November 24, 2025 SDBN Comments Off

As the life sciences market continues to face significant pain, a massive lab development over the Massachusetts Turnpike has paused until conditions improve. San Diego-based IQHQ announced that its $1B, 960K SF Fenway Center project isn’t moving […]

Science Today for a Healthier Tomorrow

November 24, 2025 SDBN Comments Off

In a series of videos, graduate students and researchers in biochemistry professor Alexis Komor’s lab share what they’re working on and the importance of federal funding. Click here to view original post Click Here to […]

5 Science-Backed Reasons to Express Gratitude, according to UC San Diego Research

November 24, 2025 SDBN Comments Off

According to research led by Christopher Oveis, an associate professor at the University of California San Diego Rady School of Management, expressing gratitude doesn’t just make others feel good. It can strengthen relationships, reduce stress […]

Blacksmith Medicines Secures European Patent Allowance for LpxC-Targeting Antibacterial Compounds

November 24, 2025 SDBN Comments Off

SAN DIEGO, Nov. 24, 2025 /PRNewswire/ — Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the European Patent Office has issued a Notice of Intention […]

Actio Biosciences to Present New Preclinical Data for ABS-1230, a KCNT1 Inhibitor for the Treatment of KCNT1-Related Epilepsy, at the American Epilepsy Society Annual Meeting

November 24, 2025 SDBN Comments Off

SAN DIEGO–(BUSINESS WIRE)–Actio Biosciences, a clinical-stage biotechnology company advancing the translation of genetic insights into novel precision medicines, today announced it will present new preclinical data from its ABS-1230 program for the treatment of KCNT1-related […]

Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025

November 24, 2025 SDBN Comments Off

–Findings support the versatility of Capricor’s exosome technology, enabling efficient and scalable loading of siRNAs and PMOs to support future clinical development– SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) — Capricor Therapeutics, Inc., (NASDAQ: CAPR), […]

Salimetrics Launches ‘Tools for Your Toolbox’ to Improve Research Study Management

November 24, 2025 SDBN Comments Off

CARLSBAD, Calif., Nov. 24, 2025 /PRNewswire/ — Building on the Salimetrics CoreLab+ research testing platform, Salimetrics announces the launch of its valuable organization, logistics, and statistical data tools to help investigators improve the efficiency of […]

MathWorks Showcases AI for Safety-Critical Systems at NeurIPS 2025

Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares

New Bilingual Opera Explores Migrant Journey in ‘Pancho Rabbit and the Coyote’

Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC

Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares

The Inner Circle acknowledges, Kari Lynn Purcott, MD, FACOG, as a Pinnacle Lifetime Member

AltPep Corporation Presents New Preclinical Data at CTAD 2025 Demonstrating SOBIN-AD, its Custom-Designed Peptide for Alzheimer’s Disease, Improves Behavior in Both Symptomatic and Asymptomatic Disease

Circular Genomics Announces Closure of $15 Million Series A Financing to Advance First-in-Class Circular RNA Platform for Early Detection of Alzheimer’s Disease

Connect Strengthens Leadership Team with Promotion of Cait Kelly to Chief Strategy Officer

INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer’s Patients

Nobel Prize-Winning Metal-Organic Frameworks Are the Jungle Gyms of Chemistry

New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease

Protego gets $130M for AL amyloidosis drug from leaders behind Vyndaqel

Protego Biopharma Raises $130 Million Oversubscribed Series B Financing to Advance First-in-Class AL Amyloidosis Program into Pivotal Study

Telix Pharmaceuticals Ltd. Shareholders with Large Losses Should Contact Robbins LLP for Information About the TLX Class Action

Scripps Oceanography Seismologist Awarded for Real-Time Tsunami Forecast Breakthrough

Nine Breakthroughs Made Possible by AI

Genetic Study Links Impulsive Decision Making to a Wide Range of Health and Psychiatric Risks

IQHQ Halts Development On $1B Fenway Center Life Sciences Project

Science Today for a Healthier Tomorrow

5 Science-Backed Reasons to Express Gratitude, according to UC San Diego Research

Blacksmith Medicines Secures European Patent Allowance for LpxC-Targeting Antibacterial Compounds

Actio Biosciences to Present New Preclinical Data for ABS-1230, a KCNT1 Inhibitor for the Treatment of KCNT1-Related Epilepsy, at the American Epilepsy Society Annual Meeting

Capricor Therapeutics Presents New Data Demonstrating a Scalable Framework for Loading Therapeutic Oligonucleotides into Exosomes at AAEV 2025

Salimetrics Launches ‘Tools for Your Toolbox’ to Improve Research Study Management

Protecting Patients’ Online Lives

What’s Happening to Our Food?

What’s Fueling Colorectal Cancer in Young Adults

Outdoor UC San Diego Shake Table Shakes Again

Virus Battles Drug-Resistant Infections

Want to Save Time?

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox